tiprankstipranks
Advertisement
Advertisement

ALNY Stock Latest News

Alnylam’s New Hypertension Combo Study Could Reshape Its Long-Term Value
Company AnnouncementsAlnylam’s New Hypertension Combo Study Could Reshape Its Long-Term Value
3d ago
ALNY
Alnylam Steps Into Obesity Drug Race With New ALN-2232 Trial
PremiumCompany Announcements
Alnylam Steps Into Obesity Drug Race With New ALN-2232 Trial
3d ago
ALNY
Alnylam’s New Phase 1 ALN-4915 Trial: Early Safety Data in Focus for ALNY Investors
PremiumCompany Announcements
Alnylam’s New Phase 1 ALN-4915 Trial: Early Safety Data in Focus for ALNY Investors
3d ago
ALNY
Alnylam’s HMBeacon Trial Adds a New Growth Angle in Women’s Bleeding Disorders
PremiumCompany Announcements
Alnylam’s HMBeacon Trial Adds a New Growth Angle in Women’s Bleeding Disorders
3d ago
ALNY
PLTR, KTOS, ALNY: 3 High P/E Stocks with 40%+ Upside Potential in 2026
PremiumMarket News
PLTR, KTOS, ALNY: 3 High P/E Stocks with 40%+ Upside Potential in 2026
4d ago
ALNY
KTOS
Alnylam announces new analyses from HELIOS-B study of vutrisiran
PremiumThe FlyAlnylam announces new analyses from HELIOS-B study of vutrisiran
5d ago
ALNY
MBX Biosciences appoints Mark Soued as chief commercial officer.
Premium
The Fly
MBX Biosciences appoints Mark Soued as chief commercial officer.
10d ago
MBX
ALNY
Alnylam Maintained at Buy as Strong TTR-Driven Momentum and Pipeline Progress Support Unchanged $510 Price Target
Premium
Ratings
Alnylam Maintained at Buy as Strong TTR-Driven Momentum and Pipeline Progress Support Unchanged $510 Price Target
12d ago
ALNY
Alnylam price target raised to $370 from $360 at Morgan Stanley
PremiumThe Fly
Alnylam price target raised to $370 from $360 at Morgan Stanley
16d ago
ALNY
Alnylam price target lowered to $447 from $448 at Bernstein
PremiumThe Fly
Alnylam price target lowered to $447 from $448 at Bernstein
16d ago
ALNY
Outside Review Warns Alnylam Pharmaceuticals Stock Carries High Risk of Significant Losses
PremiumCompany Announcements
Outside Review Warns Alnylam Pharmaceuticals Stock Carries High Risk of Significant Losses
16d ago
ALNY
Alnylam Earnings Call Highlights TTR-Fueled Breakout
PremiumCompany Announcements
Alnylam Earnings Call Highlights TTR-Fueled Breakout
16d ago
ALNY
Alnylam reports Q1 EPS $1.99, consensus $1.47
PremiumThe FlyAlnylam reports Q1 EPS $1.99, consensus $1.47
17d ago
ALNY
Myles Minter Reiterates Buy on Alnylam After Strong Beat, Reaffirmed 2026 Outlook, and Advancing TRITON Phase III Pipeline
Premium
Ratings
Myles Minter Reiterates Buy on Alnylam After Strong Beat, Reaffirmed 2026 Outlook, and Advancing TRITON Phase III Pipeline
17d ago
ALNY
ALNY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALNY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
ALNY
Alnylam: Buy Rating Reiterated as TTR Strength and Pipeline Prospects Support Unchanged $549 Price Target
PremiumRatings
Alnylam: Buy Rating Reiterated as TTR Strength and Pipeline Prospects Support Unchanged $549 Price Target
20d ago
ALNY
Alnylam’s New Diabetes Study Puts Insulin Sensitivity in the Spotlight
PremiumCompany Announcements
Alnylam’s New Diabetes Study Puts Insulin Sensitivity in the Spotlight
29d ago
ALNY
Alnylam price target lowered to $505 from $515 at Truist
PremiumThe Fly
Alnylam price target lowered to $505 from $515 at Truist
1M ago
ALNY
Seanergy, Arqit, Verisign, Alnylam, Lamb Weston Shake-Up
PremiumWeekend Updates
Seanergy, Arqit, Verisign, Alnylam, Lamb Weston Shake-Up
1M ago
LW
ALNY
BioCryst appoints Sandeep Menon as chief research and development officer
PremiumThe FlyBioCryst appoints Sandeep Menon as chief research and development officer
1M ago
ALNY
BCRX
Alnylam’s DemonsTTRate Study: Real-World Data Could Shift the ATTR-CM Investment Story
Premium
Company Announcements
Alnylam’s DemonsTTRate Study: Real-World Data Could Shift the ATTR-CM Investment Story
2M ago
ALNY
Alnylam presents new data on vutrisiran in ATTR-CM at ACC.26
Premium
The Fly
Alnylam presents new data on vutrisiran in ATTR-CM at ACC.26
2M ago
ALNY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >